Medicare Enrolled

Dr. Francisco Flores, M.D.

MOHS-Micrographic Surgery Physician · Miramar, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
14601 SW 29TH ST, Miramar, FL 33027
9548855551
In practice since 2005 (20 years)
NPI: 1114914934 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Flores from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flores? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Flores

Dr. Francisco Flores is a mohs-micrographic surgery physician in Miramar, FL, with 20 years in practice. Based on federal Medicare data, Dr. Flores performed 1,936 Medicare services across 760 unique beneficiaries.

Between the years covered by Open Payments, Dr. Flores received a total of $25,759 from 38 pharmaceutical and/or device companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Flores is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 1,936 Medicare services$ $25,759 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,936
Medicare services
Bottom 34% in FL for mohs-micrographic surgery physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
760
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~97 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-14937$5$17
Office visit, established patient (20-29 min)186$65$235
Skin biopsy, tangential164$62$265
Destruction of precancerous skin growth, 1159$35$176
Destruction of skin growths (warts/lesions), 1-14117$82$295
Biopsy of related skin growth, each additional growth72$41$131
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks60$520$1,792
Steroid injection (triamcinolone)54$1$3
New patient office visit (30-44 min)48$77$296
Destruction of precancer skin growth, 15 or more growths45$122$445
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm18$220$1,262
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks17$341$1,087
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm16$209$1,122
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less15$141$748
Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks15$499$1,661
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm13$195$800
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$25,759
Total received (2018-2024)
Avg $3,680/year across 7 years
Top 11% in FL for mohs-micrographic surgery physician
38
Companies
762
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,165 (51.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,349 (47.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$244 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,246
2023
$4,207
2022
$4,891
2021
$7,024
2020
$3,001
2019
$1,712
2018
$1,678

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
LEO Pharma Inc.
$7,650
Janssen Biotech, Inc.
$3,410
Dermavant Sciences, Inc.
$2,757
Ortho Dermatologics, a division of Bausch Health US, LLC
$2,529
PFIZER INC.
$1,416
ABBVIE INC.
$1,113
Novartis Pharmaceuticals Corporation
$1,010
AbbVie Inc.
$678
UCB, Inc.
$610
AbbVie, Inc.
$565
Lilly USA, LLC
$542
Regeneron Healthcare Solutions, Inc.
$484
GENZYME CORPORATION
$427
Medimetriks Pharmaceuticals, Inc.
$350
Genentech USA, Inc.
$331
Encore Dermatology Inc.
$296
Incyte Corporation
$282
Amgen Inc.
$225
Almirall LLC
$211
VYNE Pharmaceuticals Inc.
$140
ORGANOGENESIS INC.
$110
Sun Pharmaceutical Industries Inc.
$104
Helsinn Therapeutics (U.S.), Inc.
$63
Kyowa Kirin, Inc.
$63
Arcutis Biotherapeutics, Inc.
$62
DERMIRA, INC.
$47
Celgene Corporation
$45
E.R. Squibb & Sons, L.L.C.
$40
SUN PHARMACEUTICAL INDUSTRIES INC.
$34
Organogenesis Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Verrica Pharmaceuticals Inc.
$20
MAYNE PHARMA COMMERCIAL LLC
$19
Phadia US Inc.
$18
MAYNE PHARMA INC.
$18
Galderma Laboratories, L.P.
$16
Sebela Pharmaceuticals Inc.
$14
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 53.6% of total payments
Associated products mentioned in payments ›
ABSORICA · ADBRY · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Acticlate · Aczone · BRYHALI · Bimzelx · CIBINQO · COSENTYX · Cimzia · DERMATITIS - DISEASE · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · ImmunoCAP · Impoyz · JUBLIA · Ketodan · Klisyri · NAFTIN · OPZELURA · Otezla · POTELIGEO · Puraply · Puraply Antimicrobial · QBREXZA · REMICADE · RETIN-A · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · SPRYCEL · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE · VALCHLOR · VTAMA · Veltin · Verdeso · Winlevi · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (51%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $1,331 per 100 Medicare services performed
Looking for a mohs-micrographic surgery physician in Miramar?
Compare mohs-micrographic surgery physicians in the Miramar area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

MOHS-Micrographic Surgery Physicians within 10 mi
24
Per 100K population
1.2
County median income
$74,534
Nearest hospital
MEMORIAL HOSPITAL WEST
1.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Flores is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Flores experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Flores performed 937 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Flores receive payments from pharmaceutical companies?
Yes. Dr. Flores received a total of $25,759 from 38 companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Flores's costs compare to other mohs-micrographic surgery physicians in Miramar?
Dr. Flores's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Flores) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →